Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: Comparison with tyramine and β-phenylethylamine

British Journal of Pharmacology

Volumn 165, Issue 7, 2012, Pages 2191-2202

  Anwar, M A ^a   Ford, W R ^a   Broadley, K J ^a   Herbert, A A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

phenylethylamine; 5 HT receptors; mesenteric vasculature; rat; trace amine associated receptors; trace amines; tryptamine; tyramine

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; KETANSERIN; N(G) NITROARGININE METHYL ESTER; PHENETHYLAMINE; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; RECEPTOR; RITANSERIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; TRACE AMINE ASSOCIATED RECEPTOR; TRYPTAMINE; TYRAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERY PERFUSION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; PERFUSION; PHENETHYLAMINES; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN; TRYPTAMINES; TYRAMINE; VASOCONSTRICTION; VASODILATION;

EID: 84858204537     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01706.x     Document Type: Article

References (59)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Anwar MA, Ford WR, Broadley KJ, (2009). Constrictor and dilator responses to tryptamine in the isolated perfused mesenteric arterial circulation of the rat. Proc Br Pharmacol Soc pA2 online 7: 001P.
3. Barger G, Dale HH, (1910). Chemical structure and sympathomimetic actions of amines. J Physiol 41: 19-59.
4. Bockman CS, Gonzalez-Cabrera I, Abel PW, (1996). Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats. J Pharmacol Exp Ther 278: 1235-1243. (Pubitemid 27166974)
5. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, et al,. (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 98: 8966-8971. (Pubitemid 32743853)
6. Bradley PB, Humphrey PPA, Williams RH, (1985). Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors. Br J Pharmacol 84: 919-925. (Pubitemid 15108094)
7. Broadley KJ, (2010). The vascular effects of trace amines and amphetamines. Pharmacol Ther 125: 363-375.
8. Broadley KJ, Anwar MA, Herbert AA, Fehler M, Jones EM, Davies WE, et al,. (2009). Effects of dietary amines on the gut and its vasculature. Br J Nutr 101: 1645-1652.
9. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, et al,. (2001). Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60: 1181-1188. (Pubitemid 33144888)
10. Burn JH, Rand MJ, (1958). The action of sympathomimetic amines in animals treated with reserpine. J Physiol 144: 314-336.
11. 2 receptor antagonists. Br J Pharmacol 89: 129-135. (Pubitemid 16031212)
12. 7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J Pharmacol Exp Ther 277: 1560-1566.
13. Dale HH, Dixon WE, (1909). The action of pressor amines produced by putrefaction. J Physiol 39: 25-44.
14. Eble JN, (1965). A study of the potentiation of tryptamine by monamine oxidase inhibitors in the dog. J Pharmacol Exp Ther 148: 48-53.
15. Elliott J, Callingham BA, Sharman DF, (1989). The influence of amine metabolizing enzymes on the pharmacology of tyramine in the isolated perfused mesenteric arterial bed of the rat. Br J Pharmacol 98: 515-522. (Pubitemid 19245760)
16. Fehler M, Broadley KJ, Ford WR, Kidd EJ, (2010). Identification of trace amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine. Naunyn Schmiedebergs Arch Pharmacol 382: 385-398.
17. Franzen F, Gross H, (1965). Tryptamine, N,N-dimethyltryptamine, N,N-dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine. Nature 206: 1052.
18. Frascarelli S, Ghelardoni S, Chiellini G, Vargiu R, Ronca-Testoni S, Scanlan TS, et al,. (2008). Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors. Eur J Pharmacol 587: 231-236.
19. Grandy DK, (2007). Trace amine-associated receptor 1-family archetype or iconoclast? Pharmacol Ther 116: 355-390. (Pubitemid 350123635)
20. 2A receptor desensitization. Biochemistry 42: 10853-10862. (Pubitemid 37102125)
21. 7 anatagonist. Br J Pharmacol 130: 539-548. (Pubitemid 30332971)
22. Hawthorn MH, Broadley KJ, Gibbons CJ, (1985). Examination of the bronchoconstrictor response of guinea-pig isolated lung to beta- phenylethylamine. Gen Pharmacol 16: 371-378. (Pubitemid 15237694)
23. Herbert AA, Kidd EJ, Broadley KJ, (2008). Dietary trace amine-dependent vasoconstriction in porcine coronary artery. Br J Pharmacol 155: 525-534.
24. Hicks PE, Langer SZ, (1983). Antagonism by tetra-hydro-β-carboline of the vasoconstrictor responses to tryptamine in rat tail arteries. Eur J Pharmacol 96: 145-149. (Pubitemid 14222424)
25. Hoffman BB, Lefkowitz RJ, (1990). Adrenergic receptor antagonists. In:, Gilman AG, Rall TW, Nies AS, Taylor P, (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th edn. Pergamon Press: New York, pp. 221-243.
26. Hoyer D, Hannon JP, Martin GR, (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554. (Pubitemid 34219205)
27. 7 receptors mediate relaxation of porcine pial veins. Am J Physiol 278: H907-H912. (Pubitemid 30152548)
28. Kaitaniemi S, Elovaara H, Grön K, Kidron H, Liukkonen J, Salminen T, et al,. (2009). The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase. Cell Mol Life Sci 66: 2743-2757.
29. 7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br J Pharmacol 117: 926-930.
30. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC, (2005). Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85: 372-385. (Pubitemid 40249429)
31. 7 antagonist: (R)-3-(2-(2-(4-methyl-piperidin-1-yl)-ethyl) pyrrolidine-1-sulfonyl) phenol (SB-269970). J Med Chem 43: 342-345.
32. Marin C, Sanchez CF, (1980). Influence of calcium on noradrenaline release evoked by 5-hydroxytryptamine and potassium from goat pial arteries. J Pharm Pharmacol 32: 643-646. (Pubitemid 11251682)
33. Martin GR, (1994). Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol Ther 62: 283-324. (Pubitemid 24248421)
34. Martin GR, Humphrey PPA, (1994). Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neurophysiology 33: 261-273. (Pubitemid 24168699)
35. Masuzawa K, Matsuda T, Asano M, (1989). Decreased arterial responsiveness to multiple cyclic AMP-generating receptor agonists in spontaneously hypertensive rats. Br J Pharmacol 96: 227-235. (Pubitemid 19037390)
36. Mcgregor DD, (1965). The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol 177: 21-30.
37. McLennan PL, Taylor DA, (1984). Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation. Eur J Pharmacol 104: 313-318. (Pubitemid 14006369)
38. Morecroft I, MacLean MR, (1998). 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries. Br J Pharmacol 125: 69-78. (Pubitemid 28418758)
39. Nyborg NC, Korsgaard N, Mulvany MJ, (1986). Neonatal sympathectomy of normotensive Wistar-Kyoto and spontaneously hypertensive rats with 6-hydroxydopamine: effects on resistance vessel structure and sensitivity to calcium. J Hypertens 4: 455-461. (Pubitemid 17001475)
40. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 96: 434-440. (Pubitemid 19045120)
41. 2C receptors in CHO-K1 cells. Br J Pharmacol 128: 13-20. (Pubitemid 29425262)
42. 2 receptor desensitization. Eur J Pharmacol 238: 173-180. (Pubitemid 23214429)
43. Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA, (2006). Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med 8: 1-27. (Pubitemid 44322753)
44. Sloan JW, Martin WR, Clements TH, Buchwald WF, Bridges SR, (1975). Factors influencing brain and tissue levels of tryptamine: species, drugs and lesions. J Neurochem 24: 523-532.
45. Sotnikova TD, Caron MG, Gainetdinov RR, (2009). Trace amine-associated receptors as emerging therapeutic targets. Mol Pharmacol 76: 229-235.
46. Stollak JS, Furchgott RF, (1983). Use of selective anatagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta. J Pharmacol Exp Ther 224: 215-221. (Pubitemid 13171052)
47. Su C, Uruno T, (1984). Excitatory and inhibitory effects of 5-hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats. Eur J Pharmacol 106: 283-290. (Pubitemid 15210617)
48. SulliVan JL, Coffey CE, Basuk B, Cavenar JO, Malthie AA, Zung WW, (1980). Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity. Biol Psychiatry 15: 113-120. (Pubitemid 10176448)
49. SulliVan JP, McDonnell L, Hardiman OM, Farrell MA, Phillips JP, Tipton KF, (1986). The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues. Biochem Pharmacol 35: 3255-3260. (Pubitemid 16001432)
50. Sumner MJ, (1991). Characterization of the 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava. Br J Pharmacol 102: 938-942.
51. 7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br J Pharmacol 127: 609-616. (Pubitemid 29276645)
52. Trendelenburg U, (1972). Classification of sympathomimetic amines. In:, Blaschko H, Muscholl E, (eds). Catecholamines, Handbook of Experimental Pharmacology, Vol. 33. Springer-Verlag: Berlin, pp. 336-362.
53. Trevethick MA, Fenuik W, Humphrey PPA, (1986). 5-Carboxamido-tryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. Life Sci 38: 1521-1528. (Pubitemid 16069407)
54. Van Der Graaf PH, Saxena PR, Shankley NP, Black JW, (1995). Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries. Br J Pharmacol 116: 3237-3242. (Pubitemid 26007768)
55. Van Nueten JM, Schuurkes JAJ, De Ridder WJE, Kuyps JJMD, Janssens WJ, (1986). Comparative pharmacological profile of ritanserin and ketanserin. Drug Dev Res 8: 187-195. (Pubitemid 16078137)
56. 2C receptors and their atypical regulation properties. Life Sci 72: 2429-2449. (Pubitemid 36321816)
57. Watts SW, (2002). Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension 39: 825-829. (Pubitemid 34252884)
58. 2B receptor mediates contraction in the mesenteric artery of mineralcorticoid hypertensive rats. Hypertension 26: 1056-1059.
59. Zucchi R, Chiellini G, Scanlan TS, Grandy DK, (2006). Trace amine-associated receptors and their ligands. Br J Pharmacol 149: 967-978. (Pubitemid 44950800)